Survival
The cutoff time for the analyses was April 2023 and resulted in a median follow-up of 26.6 months (3.8–29.0 months), and six patients (20.0%) died over this period. The median OS was 19.8 months (95% CI = 9.8–29.7 months). The median PFS was 6.4 months (95% CI = 1.5–11.2 months). The good compliance group had a significantly longer median OS compared with the poor compliance group (25.3 months vs. 7.9 months, HR = 0.306, 95% CI = 0.120–0.784, Survival outcomes according to the exercise compliance group. 